Literature DB >> 2521207

Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin.

A Tsafriri1, T A Bicsak, S B Cajander, T Ny, A J Hsueh.   

Abstract

Indirect evidence has suggested a role for plasminogen activator (PA) in ovulation. Our recent studies demonstrated that 1) tissue-type PA (tPA) is the predominant PA produced by preovulatory rat follicles in response to gonadotropins or GnRH; and 2) several inhibitors of the serine proteases, to which PA and plasmin belong, block ovulation. Here, the role of tPA and plasmin in ovulation was examined directly by the use of specific antibodies to tPA and alpha 2-antiplasmin (alpha 2AP). Immature female rats at 25-26 days of age were treated (sc) with 15 IU PMSG to induce multiple preovulatory follicles. Fifty-four hours later, tPA antibodies and alpha 2AP were injected into one of the ovarian bursae to check their ability to block ovulation, which was initiated with an ovulatory dose (4 IU) of hCG. The data are expressed as percent inhibition of ovulation in the treated vs. the untreated ovaries. A significant decrease in the ovulation rate was obtained by administration of 500 micrograms antibodies to tPA (39.6%) or 1-50 micrograms alpha 2AP (36-44%), whereas minimal inhibition (12%) was found at lower doses of anti-tPA (10 micrograms) or alpha 2AP (0.1 micrograms). Furthermore, nonimmune immunoglobulin G (500 micrograms) and heat-inactivated alpha 2AP were not effective. Anti-tPA and alpha 2AP suppressed ovulation only when injected at the time of hCG administration; later injections (4-h delay) were ineffective, suggesting that PA and plasmin are involved in the early follicular responses to the ovulatory stimulus. Histological observation of the ovaries did not reveal any pathological changes associated with the anti-tPA and alpha 2AP treatment. Suppression of ovulation, as evidenced by decreased number of tubal ova, was frequently accompanied with intraovarian release of the eggs into the follicular thecal compartment. Thus, these results provide direct evidence for an essential role of tPA and plasmin in ovulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521207     DOI: 10.1210/endo-124-1-415

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

Review 1.  The plasminogen activator/plasmin system.

Authors:  J D Vassalli; A P Sappino; D Belin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

Review 2.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

3.  Induction of Tissue Factor Pathway Inhibitor 2 by hCG Regulates Periovulatory Gene Expression and Plasmin Activity.

Authors:  Muraly Puttabyatappa; Linah F Al-Alem; Farnosh Zakerkish; Katherine L Rosewell; Mats Brännström; Thomas E Curry
Journal:  Endocrinology       Date:  2017-01-01       Impact factor: 4.736

4.  Interleukin-1β inhibits luteinizing hormone-induced plasminogen activator activity in rat preovulatory folliclesin vitro.

Authors:  N P Bonello; R J Norman; M Brännström
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

5.  Interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system in follicular growth and ovulation.

Authors:  Y Yoshimura; N Aoki; K Sueoka; T Miyazaki; N Kuji; M Tanaka; T Kobayashi
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle.

Authors:  Nune Markosyan; Diane M Duffy
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

7.  Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.

Authors:  P Carmeliet; L Kieckens; L Schoonjans; B Ream; A van Nuffelen; G Prendergast; M Cole; R Bronson; D Collen; R C Mulligan
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Transcriptional regulation of the rat tissue type plasminogen activator gene: localization of DNA elements and nuclear factors mediating constitutive and cyclic AMP-induced expression.

Authors:  M Ohlsson; G Leonardsson; X C Jia; P Feng; T Ny
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

Review 9.  Epidermal growth factor, from gene organization to bedside.

Authors:  Fenghua Zeng; Raymond C Harris
Journal:  Semin Cell Dev Biol       Date:  2014-02-07       Impact factor: 7.727

10.  Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators.

Authors:  G Leonardsson; X R Peng; K Liu; L Nordström; P Carmeliet; R Mulligan; D Collen; T Ny
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.